Targeting TKI-Activated NFKB2-MIF/CXCLs-CXCR2 Signaling Pathways in FLT3 Mutated Acute Myeloid Leukemia Reduced Blast Viability

por Cao, Huynh, Tadros, Verena, Hiramoto, Benjamin, Leeper, Kevin, Hino, Christopher, Xiao, Jeffrey, Pham, Bryan, Kim, Do Hyun, Reeves, Mark E., Chen, Chien-Shing, Zhong, Jiang F., Zhang, Ke K., Xie, Linglin, Wasnik, Samiksha, Baylink, David J., Xu, Yi
Publicado 2022